Testing effectiveness (Phase 2)Study completedNCT00880269
What this trial is testing
Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)
Who this might be right for
Refractory LeukemiaAcute Myelogenous Leukemia
Novartis Pharmaceuticals 59